SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-24-006592
Filing Date
2024-02-14
Accepted
2024-02-14 16:00:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 formsc13g.htm SC 13G 106428
2 ex1.htm EX-1 12694
  Complete submission text file 0001493152-24-006592.txt   120742
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88552 | Film No.: 24637395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 767 FIFTH AVENUE 15TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVENUE 15TH FLOOR NEW YORK NY 10153 646-993-6330
Irenic Capital Management LP (Filed by) CIK: 0001929389 (see all company filings)

IRS No.: 873544472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G